The Beneficial Effects of Combining Anti-Aβ Antibody NP106 and Curcumin Analog TML-6 on the Treatment of Alzheimer’s Disease in APP/PS1 Mice

Alzheimer’s disease (AD) is a progressive neurodegenerative disease with a multifactorial etiology. A multitarget treatment that modulates multifaceted biological functions might be more effective than a single-target approach. Here, the therapeutic efficacy of combination treatment using anti-Aβ an...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Ih-Jen, Hsu, Chia-Yu, Shen, Santai, Chao, Po-Kuan, Hsu, John Tsu-An, Hsueh, Jung-Tsung, Liang, Jia-Jun, Hsu, Ying-Ting, Shie, Feng-Shiun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745390/
https://www.ncbi.nlm.nih.gov/pubmed/35008983
http://dx.doi.org/10.3390/ijms23010556

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8745390/
https://www.ncbi.nlm.nih.gov/pubmed/35008983
http://dx.doi.org/10.3390/ijms23010556

Ejemplares similares